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Summary Juvenile angiofibroma (JA) is a relatively rare lesion that most com-
monly affects the nasal and paranasal cavity of young individuals, with maximal
prevalence in males and with well characterised clinico-radiological features.
Intra-oral JA are exceedingly rare, two such cases having been reported so far.
We report on the clinical, radiological and histopathological features of a JA affect-
ing the posterior right maxillary bone of a 21 year old female, presenting as a gin-
gival expansion and associated with an impacted third molar.
Clinical examination and imaging studies did not allow proper discrimination from
several gingival and bone lesions and the patient underwent incisional biopsy at a
pre-operative stage. This resulted in a collection of haphazardly arranged and var-
iably sized vascular channels, resembling capillaries, sinusoids and veins embedded
within a collagenous stroma of variable density. The lesion did not show peripheral
demarcation and permeated the surrounding bone. The patient underwent maxillary
en-block resection and remained disease-free after a 3-year follow-up.
In view of its extreme rarity, intra-oral JA are difficult to diagnose at a pre-oper-
ative stage and incisional biopsies may surely help to choose the most appropriate
treatment in consideration of the relatively high recurrence rates of this lesion of
possible malformative nature.c 2004 Elsevier Ltd. All rights reserved.
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Juvenile angiofibroma (JA) is an uncommon be-
nign vascular tumour almost exclusively occuring
in the nasal and paranasal cavities of adolescentrved.
Figure 1 Panoramic radiograph at the time of extrac-
tion of 2 upper right molars; the impacted third right
maxillary molar is evident, surrounded by almost normal
alveolar bone.
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all tumours of the maxillo-facial area.3
It is characterised morphologically by irregular,
proliferating vascular channels within a fibrous
stroma, which consists of plump, spindle or stel-
late, cells. It has a peculiar propensity for local
extension into the adjacent tissues that often pre-
cludes complete surgical resection and likely is
responsible for tumour persistence and recurrences
in 21–34% of the affected patients.3,4
Topographically, this tumour frequently origi-
nates in the postero-lateral wall of the nasal cav-
ity, close to the superior margin of the spheno-
palatine foramen. Subsequently, JA may cause
bone erosion and displacement of adjacent struc-
tures, thus involving the nasophrynx, paranasal,
ethmoidal and maxillary sinuses, orbit and skull
base, with possible intracranical extension.3–5
JAs usually are staged according to the Fisch
classification system6 in a 4-tired scale, mainly
based on radiological findings: stage I = tumours
limited to the nasal cavity and nasopharynx with-
out bone destruction; stage II = tumours invading
the pterygo-maxillary fossa and/or the paranasal
sinuses with bone destruction; stage III = tumours
invading the infratemporal fosssa, orbit and/or
the parasellar region, remaining laterally to the
cavernous sinus; stage IV = tumours invading the
cavernous sinus, optical chiasma and/or the pitui-
tary fossa.
JA with involvement of intra-oral structures or
presenting as an intra-oral neoplasm is exceedingly
rare, only two cases having been reported thus far
by Kabot et al. in 19857, and by Antoniades et al. in
20025; in both instances the tumour involved the
maxillary alveolar bone and the hard palate.
In view of the extreme rarity of JA as an intra-
oral neoplasm and in consideration of the problem-
atic differential diagnosis for such an uncommon
neoplasm, we report on the clinico-radiological
and histopathological features of a JA that pre-
sented as an intra-oral exophytic mass in a 21-
years-old white girl who was successfully treated
by surgical excision.Figure 2 Clinical appearance of intra-oral lesion on the
vestibular aspect at the time of hospitalisation, four
months after teeth extraction; a gingival swelling is
evident extending from the tuber maxillae to the
interdental papilla between the first and the second
premolars.Case report
A 21-years-old white girl was hospitalised for a
right palatal swelling associated with an impacted
upper 3rd molar and with mobility of the adjacent
1st upper molar of 4-month duration. This lesion
had been interpreted by the dental practitioner
as reactive gingival hyperplasia, possibly due to bit-
ing trauma. The original panoramic radiogramshowed the impacted 3rd molar associated with a
poorly defined weak radiolucency of the surround-
ing maxillary bone (Fig. 1). Consequently, extrac-
tions of the 1st and 3rd molars were performed
by the dental practitioner, along with marginal gin-
gival resection.
At the time of hospitalisation, the patient com-
plained for rapid growth and bleeding of the gingi-
val lesion that had almost doubled its original size
after the aforementioned procedures.
Physical examination of the oral cavity revealed
a firm and painful mass of the posterior hard pal-
ate, both on the lingual and vestibular aspects,
measuring 4.5cm. in maximum diameter and
extending from the interdental papilla of the first
and second right premolar to the tuber maxillae
Figure 3 Coronal CT scan at the level of premolars
shows the anterior extension of the lesion; this appears
as a mixed radiolucent/radiotransparent lesion associ-
ated with minimal erosion of the floor of the left
maxillary sinus with erosion of the cortical maxillary
bone and intra-oral expansion.
Figure 4 Histopathological features of JA. Numerous
vascular channels of variable size and architecture are
present within a dense fibrous stroma (Haematoxylin-
Eosin, x100).
Figure 5 At higher magnification some of the blood
vessels resemble capillary or sinusoidal vessels with a
very thin wall while others show an evident thick wall
composed by myo-pericytic cells. The interposed stroma
is organised in dense collagen bundles or in loosely
arranged, myxoid appearing fascicles (Haematoxylin-
Eosin, x250).
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epithelium and associated with mobility of the 1st
and 2nd homo-lateral premolars. The patient had
not nasal obstruction or epistaxis but she referred
chewing difficulty. No homo-lateral lymphadenopa-
thies were detectable. A new panoramic radio-
graph was performed that showed minimal
rarefaction of the alveolar bone with enlargement
of parodontal space of the 2nd and 1st premolars.
A CT-scan was subsequently performed that dis-
played irregular bone resorption of the right max-
illa (Fig. 3), extending from the alveolar bone to
the posterior wall of the nasal cavity and associ-
ated with bone erosion of the floor of the nasal cav-
ity, without apparent extension into the nasal or
paranasal cavities.
With the clinical suspicion of intra-osseous
malignant tumour, the patient underwent an inci-
sional biopsy under local anaesthesia. Following
the histological diagnosis of angiofibroma, the pa-
tient was subjected to maxillary en-block resec-
tion, extending from the 1st premolar to the floor
of the nasal cavity, without pre-operative emboli-
sation, and under general anaesthesia, after
clumping of the right major palatal artery.The surgical specimen was promptly fixed in
neutral buffered formalin, embedded in paraffin,
cut and stained with haematoxylin-eosin (H & E).
Histologically, the tumour was mainly composed
of fibrous tissue with interspersed abundant vascu-
lar channels (Fig. 4). The latter were lined by a sin-
gle layer of flat to plump endothelial cells, and
showed architectural variability from small capil-
laries with a distinct thin wall, to sinusoidal ectatic
vessels, to larger vessels of venous type, showing
a distinct muscle cell layer (Fig. 5). The fibrous
Figure 6 Intra-osseous extension of JA. The lesion
seems to permeate through pre-existing bone trabecu-
lae, thus replacing the bone marrow. At variance with
the extra-osseous component of the lesion, the intra-
osseous counterpart is mainly composed by thin-walled
blood vessels surrounded by loose connective tissue
(Haematoxylin-Eosin, x200).
4 S. Capodiferro et al.stroma consisted of abundant collagenous fibres of
variable density and stellate or ovoid spindle cells
resembling myofibroblasts without evident atypia
or mitotic activity. The neoplasm did not show
any marginal demarcation and directly extended
into the adjacent bone (Fig. 6). These morphologi-
cal features were consistent with the diagnosis of
juvenile angiofibroma.
The patient has remained disease-free after a
3-year follow-up.Discussion
JA is an uncommon benign lesion accounting for
0.05% of all head and neck tumours3, and almost
exclusively affecting adolescent males (median
age: 15.3 years).7–10
This lesion has been variably named in the liter-
ature until relatively recently when Friedberg de-
fined it as ‘‘angiofibroma’’.11 It usually affects
the posterior nasal cavity, in close relationship
with the spheno-palatine foramen,3,5,7 even if
some authors maintain its origin in the pterygo-
palatine fossa11, with subsequent spread through
natural foraminas and fissures to the adjacent
structures 3,5,12.
Nasal obstruction and recurrent epistaxis are
the early symptoms that can suggest the diagnosis
of JA when present in an adolescent boy.12 Addi-
tional symptoms are facial swelling and bulging,headache, otalgia, hearing loss, eyelid edema,
proptosis, visual changes, sinusitis, meningi-
tis5,7,13–15. These symptoms, in association with
typical radiological findings, are very useful for
a precise clinical diagnosis and subsequent
therapy16.
Imaging studies are extremely important in the
pre-operative work-up of JA: CT and MR are usually
employed to define tumour site and extension,
especially when involvement of the skull base or
intracranial extension may be foreseen on a clinical
base. Angiography is used to define tumour blood
supply, vascular architecture and venous drainage
of the tumour. Nowadays, pre-operative embolisa-
tion can be used to decrease the need of blood
transfusion and to facilitate tumour surgical resec-
tion/ablation16.
JAs with primary intra-oral presentation are
exceedingly rare, three such cases having been
reported so far, including the current one5,7. In
view of its rarity, many other lesions may enter
in the differential diagnosis, including primary
bone lesions (fibrous dysplasia and ossifying fibro-
ma, cherubism, giant cell granuloma, osteosar-
coma), odontogenic neoplasms (ameloblastoma,
odontogenic fibroma) or gingival hyperplastic
processes (peripheral giant cell granuloma, drug-
induced hyperplasia, fibromatosis). Both clinical
examination and radiological investigations may
prove of little value to achieve a definitive diag-
nosis and the occurrence of rapid growth or bone
erosion/destruction may lead to consider malig-
nant neoplasms in the differential. For such rea-
sons, pre-operative diagnostic biopsies are
recommended to avoid unnecessary over-
treatments.
Though originally described as a locally aggres-
sive benign tumour and classified among ‘‘miscella-
neous tumours’’ in the recent WHO classification of
soft tissue tumours,17 it remains unclear whether
JA should be considered a true neoplasm or a
hamartoma (vascular malformation).
Most authors consider JA as a true neo-
plasm,2,12,14,18,19 both for the direct evidence of
expression of androgen receptors in stromal and
endothelial cell nuclei,19–21 and for the localisation
of activated transforming growth factor beta 1
(TGF-beta 1) to the fibroblasts and endothelial
cells within the neoplasm, which can play an
important role in stromal cell proliferation and
angiogenesis.2
Others have interpreted JA as hemangioma,
hyperplastic lesion, overgrowth of paraganglionic
tissue,22 hamartoma simulating the erectile tissue
of the penis,23 fibromatosis,24,25 teratoma20 or con-
genital deformity.26
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vascular growth pattern and the considerable size
and architectural variations are useful features
for adequate differential diagnosis with other vas-
cular lesions and are indicative to consider JA as
a ‘‘vascular malformation’’ or as a ‘‘vasoprolifera-
tive malformation’’.
Similarly, Schick et al.30 defined angiofibroma as
a vascular malformation and stressed that the vas-
cular component of JA can originate as a conse-
quence of incomplete regression of the first
branchial arch artery (vascular atavism). This inter-
pretation would account for the main characteris-
tics of the tumour such as the origin in the
postero-lateral nasal cavity and the main blood
supply from the maxillary artery.
Though we concur with other authors9,27–30 to
consider JA as a vascular malformation, we would
like to underline that the same histogenesis has
been considered for other benign vascular tu-
mours, such as capillary and cavernous haeman-
giomas. Persistent outgrowth of such neoplasms
may result in extension into adjacent structures
and in rare instances this may become a life-
threatening event due to tumour rupture and sub-
sequent haemorrhage. The natural clinical course
of JA is rather different as it is capable of true
invasion into adjacent structures, possibly due
to the peculiar stromal component of this lesion
that is consistently different from that of other
benign vascular lesions. This may also account
for the relatively high incidence of recurrences
(21–34% of the patients)3,4 for JA in comparison
with other vascular lesions as deep penetration
into adjacent tissues may prevent from complete
surgical removal unless wide excision are
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